The probiotic mixture IRT5 ameliorates age-dependent colitis in rats

• IRT5 increased age-suppressed expression of tight junction proteins in the colon of rats.
• IRT5 lowered age-induced gut microbiota and plasma LPS levels.
• IRT5 suppressed age-induced expression of p16 and p53.
• IRT5 inhibited age-induced activation of NF-κB and MAPKs.
• IRT5 ameliorated age-dependent colitis in the aged Fischer 344 rats.

To investigate the anti-inflammatory effect of probiotics, we orally administered IRT5 (1 × 109 CFU/rat) for 8 weeks to aged (16 months-old) Fischer 344 rats, and measured parameters of colitis. The expression levels of the inflammatory markers' inducible NO synthase (iNOS), cyclooxygenase-2 (COX2), tumor necrosis factor (TNF)-α, and interleukin (IL)-1β were higher in the colons of normal aged rats (18 months-old) than in the colons of normal young rats (6 months-old). Treatment with IRT5 suppressed the age-associated increased expression of iNOS, COX2, TNF-α, and IL-1β, and activation of NF-κB and mitogen-activated protein kinases. In a similar manner, the expression of tight junction proteins in the colon of normal aged rats was suppressed more potently than in normal young rats, and treatment of aged rats with IRT5 decreased the age-dependent suppression of tight junction proteins ZO-1, occludin, and claudin-1. Treatment with IRT5 suppressed age-associated increases in expressions of senescence markers p16 and p53 in the colon of aged rats, but increased age-suppressed expression of SIRT1. However, treatment with IRT5 inhibited age-associated increased myeloperoxidase activity in the colon. In addition, treatment with IRT5 lowered the levels of LPS in intestinal fluid and blood of aged rats, as well as the reduced concentrations of reactive oxygen species, malondialdehyde, and C-reactive protein in the blood. These findings suggest that IRT5 treatment may suppress age-dependent colitis by inhibiting gut microbiota LPS production.

Figure optionsDownload as PowerPoint slide